Bovine intestinal alkaline phosphatase (Alloksys Life Sciences)

牛肠碱性磷酸酶(Alloksys Life Sciences)

Report date: 2023/08/25 20:00:42

Base Information

Drug NameBovine intestinal alkaline phosphatase (Alloksys Life Sciences)
Drug Alias NamebIAPbRESCAPBovine alkaline phosphatase(Alloksys Life Sciences)bovine RESCAPRESCAP
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionCytokines modulatorsEndotoxin inhibitors
TargetsCytokinesEndotoxin
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSingaporePortugal +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlloksys Life Sciences Bv
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A